CAS No. |
123475-27-4 |
|---|---|
中文名称 |
(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-[(1H-吲哚-3-基)甲基]-83-[(S)-2-[(S)-2-氨基-3-(1H-咪唑-4-基)丙酰氨基]丙酰氨基]-41-(3-氨基-3-氧代丙基)-8,32-双(4-氨基丁基)-26,74-二苄基-23-[(S)-仲丁基]-29,47-双(2-羧基乙基)-65-(羧甲基)-2-(3-胍基丙基)-53-(4-羟基苄基)-71,77-双[(R)-1-羟基乙基]-56,59,68-三(羟甲基)-14,50-二异丁基-11,62-二异丙基-20,35,38-三甲基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-二十七氧代-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-二十七氮杂八十六烷二酸 |
英文名称 |
(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-((1H-indol-3-yl)methyl)-83-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-41-(3-amino-3-oxopropyl)-8,32-bis(4-aminobutyl)-26,74-dibenzyl-23-((S)-sec-butyl)-29,47-bis(2-carboxyethyl)-65-(carboxymethyl)-2-(3-guanidinopropyl)-53-(4-hydroxybenzyl)-71,77-bis((R)-1-hydroxyethyl)-56,59,68-tris(hydroxymethyl)-14,50-diisobutyl-11,62-diisopropyl-20,35,38-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-heptacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-heptacosaazahexaoctacontanedioic acid |
别名 |
Beinaglutide;L-Arginine, L-histidyl-L-alanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglycyl-;Benaglutide;L-Arginine, L-histidyl-L-alanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglyc... |
标准英文名 |
(2S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,47S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,83S)-17-((1H-indol-3-yl)methyl)-83-((S)-2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)propanamido)-41-(3-amino-3-oxopropyl)-8,32-bis(4-aminobutyl)-26,74-dibenzyl-23-((S)-sec-butyl)-29,47-bis(2-carboxyethyl)-65-(carboxymethyl)-2-(3-guanidinopropyl)-53-(4-hydroxybenzyl)-71,77-bis((R)-1-hydroxyethyl)-56,59,68-tris(hydroxymethyl)-14,50-diisobutyl-11,62-diisopropyl-20,35,38-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82-heptacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81-heptacosaazahexaoctacontanedioic acid |
分子式 |
C149H225N39O46 |
分子量 |
3298.67 |
精确分子量 |
3296.65 |
SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C |
标准SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CNC=N1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
用途 |
Beinaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist primarily used for the treatment of type 2 diabetes; it is also being developed for the treatment of obesity due to its favorable safety profile and significant weight-loss efficacy; additionally, it shows potential in the research of overweight/obesity and non-alcoholic steatohepatitis (NASH). |
InChIKey |
NGJOFQZEYQGZMB-KTKZVXAJSA-N |
|
|
评论 |
|---|